LBA11 Neoadjuvant toripalimab plus lenvatinib and GEMOX in resectable, high-risk intrahepatic cholangiocarcinoma: A randomized, multicenter, open-label phase II-III clinical trialGuobang Shi, Jian Zou, Jing Fan et al.|Annals of Oncology|2025Cited by 2
Safety analysis of weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trialTing Deng, Yi Ba, Zhi-Xiang Zhuang et al.|Journal of Chemotherapy|2013Cited by 0